Scarica l'app Stockscreener
2.27
0.00%
0.03
Precedente Chiudi:
$2.30
Aprire:
$2.22
Volume 24 ore:
27,356
Relative Volume:
0.00
Capitalizzazione di mercato:
$1.84M
Reddito:
-
Utile/perdita netta:
$-16.89M
Rapporto P/E:
-0.1087
EPS:
-20.8847
Flusso di cassa netto:
$-16.44M
1 W Prestazione:
+1.32%
1M Prestazione:
+562.06%
6M Prestazione:
+111.01%
1 anno Prestazione:
-62.26%
Intervallo 1D:
$2.22
$2.31
Intervallo di 1 settimana:
$2.18
$2.55
Portata 52W:
$0.25
$9.086
Glucotrack Inc Stock (GCTK) Company Profile
Nome
Glucotrack Inc
Settore
Industria
Telefono
972 (8) 675-7878
Indirizzo
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, RMD, ALC, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
2.30 | 2.04M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
399.64 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
181.54 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
224.67 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
65.46 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
33.98 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Glucotrack Inc Borsa (GCTK) Ultime notizie
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Australia
Why Is GlucoTrack (GCTK) in Focus? - kalkinemedia.com
Glucotrack Prices $11.5 Million Convertible Note Financing - minichart.com.sg
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Australia
Glucotrack Closes $11.6M Senior Secured Convertible Notes; Generates $4.5M Cash in Private Placement - TradingView
Glucotrack Secures $11.5 Million Convertible Debt Financing - citybiz
Glucotrack secures $11.5M in convertible note financing - Investing.com
Glucotrack Announces $11.5 Million Financing - Finviz
Why Does Glucotrack (NASDAQ:GCTK) Stand Out This Session? - kalkinemedia.com
GlucoTrack, Inc. announced that it has received $9.045015 million in funding - marketscreener.com
Glucotrack Strikes Settlement With Alto; $2M Cash Plus $2M Convertible Note at 5% - TradingView
Articles from Glucotrack - FinancialContent
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - kalkinemedia.com
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - 01net
Lōkahi Therapeutics Expands ai² Into Three Opportunity-Creating Business Divisions - Finviz
GlucoTrack Inc (GCTK) Key Financial Ratios – Valuation, Profitability & More - Value Research
Glucotrack (NASDAQ: GCTK) Announces White Lion Capital's 9.99% Stake Comprising 79,734 Shares - kalkinemedia.com
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
Near-10% Glucotrack (GCTK) holder faces ~5% cap unless limits raised - Stock Titan
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business - FinancialContent
Lōkahi Therapeutics Expands Ai2 Futures Lab Asset Origination Network Through Collaboration With San Diego State University Fowler College of Business - Moomoo
What Is Driving Glucotrack Stock? (NASDAQ:GCTK) - Kalkine Media
GlucoTrack Inc (GCTK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Glucotrack (NASDAQ: GCTK) Executes 1-for-15 Reverse Stock Split, Reducing Shares to About 798,144 - kalkinemedia.com
What Is Driving Glucotrack Stock? - Kalkine Media
Glucotrack (GCTK) adds Lokahi merger statements and pro forma results - stocktitan.net
Glucotrack (NASDAQ: GCTK) reveals 90% Lokahi stake and going-concern warning - Stock Titan
GlucoTrack Announces 1-for-15 Reverse Stock Split - The Globe and Mail
Glucotrack Sets 1-for-15 Reverse Stock Split to Address Nasdaq Requirement - citybiz
Glucotrack announces 1-for-15 reverse split to reduce shares, CUSIP update, Nasdaq compliance goal - tradingview.com
Glucotrack to implement 1-for-15 reverse stock split Monday By Investing.com - Investing.com Nigeria
Glucotrack to implement 1-for-15 reverse stock split Monday - Investing.com
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100 - Yahoo Finance
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia - marketscreener.com
Lōkahi Therapeutics Expands ai² Futures Lab Asset Origination Network Through Continued Collaboration with the University of Georgia - Finviz
Form 8K GlucoTrack Inc For: 19 August By Investing.com - Investing.com Nigeria
Glucotrack shareholders approve director elections, reverse split, and warrant inducement - Investing.com
Glucotrack Shareholders Approve Up to 1-for-30 Reverse Stock Split - minichart.com.sg
Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal - Stock Titan
GlucoTrack Stock Short Interest Rises to 33.15% - Quiver Quantitative
GlucoTrack, Inc. (GCTK) Latest Stock News & Headlines - Yahoo Finance
Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances - Yahoo Finance
Glucotrack regains Nasdaq compliance on equity requirement By Investing.com - Investing.com Canada
Glucotrack regains Nasdaq compliance on equity requirement - Investing.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Business Wire
Glucotrack Inc Azioni (GCTK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):